Related Experiment Video
Updated: Jan 20, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
Multidrug resistant tumors-aimed theranostics on the basis of strong electrostatic attraction between resistant cells
Shuwei Liu1, Lu Wang2, Shuyao Li1
1State Key Laboratory of Supramolecular Structure and Materials, College of Chemistry, Jilin University, Changchun 130012, P. R. China. hao_zhang@jlu.edu.cn.
Abstract:
Chemotherapy is one of the most common and effective ways for the clinical treatment of tumors, but tumor cells develop resistance toward drugs after a long period of chemotherapy. Interestingly, the gene expression of resistant cells usually generates increased sialic acid and raises the negative potential of the cell membranes, which is potentially useful to design novel theranostic models. In this work, we demonstrate multidrug resistant tumors-aimed theranostics by the virtue of the strong electrostatic attraction between resistant cells and nanomaterials. Human oral epithelial carcinoma vincristine-resistant tumor (KBV) and human oral epithelial carcinoma tumor (KB) were employed and compared as the tumor models. Polyethylene glycol-coated and Cu(ii) and vincristine codoped polyaniline nanoshuttles (VCR-PEG-CuPani NSs), which possessed multifunctions, positive charges, and blood circulation half-life of 6.26 ± 0.16 h, were employed as the nanomaterials for performing the tumor theranostics. Because of the stronger electrostatic attraction with KBV than that with KB, VCR-PEG-CuPani NSs showed higher enrichment of 8.05 ± 0.39% ID g-1 for KBV and a lower value of 6.02 ± 0.22% ID g-1 for KB. The higher accumulation of VCR-PEG-CuPani NSs in KBV tumors further improved the efficacy of tumor theranostics, such as those using magnetic resonance imaging, chemotherapy, and photothermal therapy.
Insights
Multidrug-resistant tumor cells attract nanomaterials due to increased negative charge. This enables targeted theranostics, combining imaging, chemotherapy, and photothermal therapy for improved cancer treatment efficacy.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Chemotherapy resistance in tumors is a significant clinical challenge.
- Resistant tumor cells exhibit increased sialic acid and negative membrane potential.
- This altered cell surface presents a unique target for novel theranostic strategies.
Purpose of the Study:
- To develop and evaluate a nanomaterial-based theranostic approach for multidrug-resistant tumors.
- To leverage the electrostatic attraction between positively charged nanomaterials and negatively charged resistant tumor cells.
- To investigate the combined efficacy of chemotherapy, magnetic resonance imaging, and photothermal therapy.
Main Methods:
- Synthesized polyethylene glycol-coated, Cu(II) and vincristine co-doped polyaniline nanoshuttles (VCR-PEG-CuPani NSs).
- Utilized human oral epithelial carcinoma vincristine-resistant (KBV) and sensitive (KB) tumor models.
- Assessed nanomaterial accumulation via electrostatic attraction and evaluated theranostic performance in vivo.
Main Results:
- VCR-PEG-CuPani NSs demonstrated enhanced accumulation in KBV tumors (8.05 ± 0.39% ID g⁻¹) compared to KB tumors (6.02 ± 0.22% ID g⁻¹).
- The nanoshuttles exhibited a favorable blood circulation half-life of 6.26 ± 0.16 hours.
- Improved theranostic outcomes were observed, including enhanced chemotherapy, MRI, and photothermal therapy efficacy in resistant tumors.
Conclusions:
- Positively charged VCR-PEG-CuPani NSs effectively target multidrug-resistant tumors via electrostatic attraction.
- This targeted approach enhances the efficacy of combined imaging, chemotherapy, and photothermal therapy.
- The developed theranostic model offers a promising strategy for overcoming chemotherapy resistance in cancer treatment.
More Related Videos
09:29In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging
Published on: April 28, 2017
10:43Expression, Detergent Solubilization, and Purification of a Membrane Transporter, the MexB Multidrug Resistance Protein
Published on: December 3, 2010
Related Concept Videos
23:06The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
09:29In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging
Resistivity
Resistance
10:43Expression, Detergent Solubilization, and Purification of a Membrane Transporter, the MexB Multidrug Resistance Protein
08:41Modeling Chemotherapy Resistant Leukemia In Vitro